Liu, L. et al. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet 388, 3027–3035 (2016).
Morens, D. M., Taubenberger, J. K. & Fauci, A. S. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 198, 962–970 (2008).
Goldblatt, D. et al. Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J. Infect. Dis. 192, 387–393 (2005).
Simell, B. et al. The fundamental link between pneumococcal carriage and disease. Expert Rev. Vaccines 11, 841–855 (2012).
Melegaro, A., Gay, N. J. & Medley, G. F. Estimating the transmission parameters of pneumococcal carriage in households. Epidemiol. Infect. 132, 433–441 (2004).
Ferreira, D. M. et al. Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults. Am. J. Respir. Crit. Care Med. 187, 855–864 (2013).
McCool, T. L., Cate, T. R., Moy, G. & Weiser, J. N. The immune response to pneumococcal proteins during experimental human carriage. J. Exp. Med. 195, 359–365 (2002).
Mina, M. J. & Klugman, K. P. The role of influenza in the severity and transmission of respiratory bacterial disease. Lancet Respir. Med. 2, 750–763 (2014).
Alpkvist, H. et al. Clinical and microbiological factors associated with high nasopharyngeal pneumococcal density in patients with pneumococcal pneumonia. PLoS ONE 10, e0140112 (2015).
Wolter, N. et al. High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia. J. Infect. Dis. 210, 1649–1657 (2014).
Albrich, W. C. et al. Pneumococcal colonisation density: a new marker for disease severity in HIV-infected adults with pneumonia. BMJ Open 4, e005953 (2014).
Thors, V. et al. The effects of live attenuated influenza vaccine on nasopharyngeal bacteria in healthy 2 to 4 year olds. A randomized controlled trial. Am. J. Respir. Crit. Care Med. 193, 1401–1409 (2016).
Mina, M. J., McCullers, J. A. & Klugman, K. P. Live attenuated influenza vaccine enhances colonization of Streptococcus pneumoniae and Staphylococcus aureus in mice. mBio 5, e01040-13 (2014).
Rylance, J. et al. Effect of live attenuated influenza vaccine on pneumococcal carriage. bioRxiv https://doi.org/10.1101/343319 (2018).
Lu, Y. J. et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 4, e1000159 (2008).
Zhang, Z., Clarke, T. B. & Weiser, J. N. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J. Clin. Investig. 119, 1899–1909 (2009).
Lu, Y. J. et al. GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis. Vaccine 28, 7468–7475 (2010).
Nakamura, S., Davis, K. M. & Weiser, J. N. Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J. Clin. Investig. 121, 3657–3665 (2011).
Sun, K. & Metzger, D. W. Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection. Nat. Med 14, 558–564 (2008).
Li, W., Moltedo, B. & Moran, T. M. Type I interferon induction during influenza virus infection increases susceptibility to secondary Streptococcus pneumoniae infection by negative regulation of γδ T cells. J. Virol. 86, 12304–12312 (2012).
Jochems, S. P., Weiser, J. N., Malley, R. & Ferreira, D. M. The immunological mechanisms that control pneumococcal carriage. PLoS Pathog. 13, e1006665 (2017).
Querec, T. D. et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10, 116–125 (2009).
Oh, J. Z. et al. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity 41, 478–492 (2014).
Li, S. et al. Metabolic phenotypes of response to vaccination in humans. Cell 169, 862–877 (2017).
Kazmin, D. et al. Systems analysis of protective immune responses to RTS,S malaria vaccination in humans. Proc. Natl Acad. Sci. USA 114, 2425–2430 (2017).
Nakaya, H. I. et al. Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 12, 786–795 (2011).
Nakaya, H. I. et al. Systems analysis of immunity to influenza vaccination across multiple years and in diverse populations reveals shared molecular signatures. Immunity 43, 1186–1198 (2015).
Li, S. et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat. Immunol. 15, 195–204 (2014).
Glennie, S. et al. Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriage. Mucosal Immunol 9, 56–67 (2015).
Karppinen, S. et al. Acquisition and transmission of Streptococcus pneumoniae are facilitated during rhinovirus infection in families with children. Am. J. Respir. Crit. Care Med. 196, 1172–1180 (2017).
Segal, A. W. How neutrophils kill microbes. Annu. Rev. Immunol. 23, 197–223 (2005).
Craft, A. W., Reid, M. M. & Low, W. T. Effect of virus infections on polymorph function in children. Br. Med. J. 1, 1570 (1976).
Yuasa, T., Ohno, S., Kehrl, J. H. & Kyriakis, J. M. Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38. J. Biol. Chem. 273, 22681–22692 (1998).
Anderson, A. C., Joller, N. & Kuchroo, V. K. Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation. Immunity 44, 989–1004 (2016).
Wu, W. et al. RIG-I and TLR3 are both required for maximum interferon induction by influenza virus in human lung alveolar epithelial cells. Virology 482, 181–188 (2015).
Malley, R. et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl Acad. Sci. USA 100, 1966–1971 (2003).
Paixao, L. et al. Host glycan sugar-specific pathways in Streptococcus pneumonia: galactose as a key sugar in colonisation and infection. PLoS ONE 10, e0121042 (2015). correction 10, e0127483 (2015).
Siegel, S. J., Roche, A. M. & Weiser, J. N. Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source. Cell Host Microbe 16, 55–67 (2014).
Russo, P. S. T. et al. CEMiTool: a Bioconductor package for performing comprehensive modular co-expression analyses. BMC Bioinformatics 19, 56 (2018).
Kwissa, M. et al. Dengue virus infection induces expansion of a CD14+CD16+ monocyte population that stimulates plasmablast differentiation. Cell Host Microbe 16, 115–127 (2014).
Parker, D. et al. Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract. mBio 2, e00016-00011 (2011).
Gerszten, R. E. et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398, 718–723 (1999).
Weiser, J. N. The pneumococcus: why a commensal misbehaves. J. Mol. Med. 88, 97–102 (2010).
Rynda-Apple, A., Robinson, K. M. & Alcorn, J. F. Influenza and bacterial superinfection: illuminating the immunologic mechanisms of disease. Infect. Immun. 83, 3764–3770 (2015).
Cox, M. A., Nechanitzky, R. & Mak, T. W. Check point inhibitors as therapies for infectious diseases. Curr. Opin. Immunol. 48, 61–67 (2017).
Hoffmann, J. et al. Viral and bacterial co-infection in severe pneumonia triggers innate immune responses and specifically enhances IP-10: a translational study. Sci. Rep. 6, 38532 (2016).
Seyoum, B., Yano, M. & Pirofski, L. A. The innate immune response to Streptococcus pneumoniae in the lung depends on serotype and host response. Vaccine 29, 8002–8011 (2011).
Luo, H., Wang, D., Che, H. L., Zhao, Y. & Jin, H. Pathological observations of lung inflammation after administration of IP-10 in influenza virus- and respiratory syncytial virus-infected mice. Exp. Ther. Med. 3, 76–79 (2012).
Hogberg, L. et al. Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci. J. Clin. Microbiol. 45, 948–952 (2007).
Madhi, S. A., Klugman, K. P. & Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat. Med. 10, 811–813 (2004).
Gritzfeld, J. F. et al. Experimental human pneumococcal carriage. J. Vis. Exp. 72, e50115 (2013).
Jochems, S. P. et al. Novel analysis of immune cells from nasal microbiopsy demonstrates reliable, reproducible data for immune populations, and superior cytokine detection compared to nasal wash. PLoS ONE 12, e0169805 (2017).
Gritzfeld, J. F. et al. Density and duration of experimental human pneumococcal carriage. Clin. Microbiol. Infect. 20, O1145–O1151 (2014).
Morton, B. et al. Augmented passive immunotherapy with P4 peptide improves phagocyte activity in severe sepsis. Shock 46, 635–641 (2016).
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).
Yates, A. et al. Ensembl 2016. Nucleic Acids Res. 44, D710–D716 (2016).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).